About Limaca
Built around a clear clinical need
Founded in 2017 as a collaboration of The Trendlines Group, Rambam Health Care Campus, and the Israel Innovation Authority, Limaca Medical was built to improve the consistency and quality of tissue acquisition in endoscopic biopsy, advancing endoscopic procedures toward more precise pancreatic cancer diagnosis.
Our Journey
Company Milestones
Company Establishment
Limaca Medical founded in collaboration with The Trendlines Group, Rambam Health Care Campus and the Israel Innovation Authority.
1st Generation Development
First-generation motorized biopsy device developed.
First-in-Human Trial
Initial first-in-human (FIH) clinical trial.
2nd Generation
Second-generation Precision-GI™ device.
FDA Breakthrough & 510(k)
FDA Breakthrough Device designation and 510(k) clearance (K231422).
Clinical Trial & TPT
Clinical trials and CMS Transitional Pass-Through (TPT) payment category.
U.S. Commercialization
Commercial launch in the United States.
Distribution Partnerships
Global distribution partnerships, including STERIS.
Experienced Leadership
Leadership
Assaf Klein
Founding CEO
A seasoned executive with over 25 years of leadership experience in the medical device industry, including orthopedics, cardiology, and gastroenterology.
Executive Team
The people behind Precision-GI™
Our Advisors
Advisors
Craig Munroe, M.D.
Medical Consultant
Gastroenterologist, interventional endoscopist, entrepreneur and global medtech executive leveraging real-world clinical and commercialization experience to advance innovation in endoscopy.
